Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 4, 1996, Pages 533-538

  Staprãns, Ilona ^a,b,c   Rapp, Joseph H ^a,b   Pan, Xian Mang ^b   Hardman, David A ^a   Feingold, Kenneth R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

corn oil; lipid peroxides; oxidized diet; polyunsaturated fat; VLDL

Indexed keywords

CORN OIL; POLYUNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIETARY INTAKE; LIPID DIET; LIPID OXIDATION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR AFFINITY;

EID: 0029942595     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.4.533     Document Type: Article

References (49)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 1989;86:1372-1376.
4. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988;241:215-218.
5. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 1989;135:815-825.
6. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoproteins in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
7. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA. 1987;84:7725-7729.
8. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1987;84:5928-5931.
9. Sparrow CP, Doebber TW, Olszewski J, Wu MS, Ventre J, Stevens KA, Chao YS. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J Clin Invest. 1992;89:1885-1891.
10. Bjokhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb. 1991;11:15-22.
11. Rosenfeld ME, Tsukada T, Chait A, Bierman EL, Gown AM, Ross R. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:24-34.
12. Rosenfeld ME, Tsukada T. Gown AM, Ross R. Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1987;7:9-23.
13. Staprans I, Rapp JH, Pan X-M, Feingold KR. The effect of oxidized lipid in the diet on serum lipoprotein peroxides in control and diabetic rats. J Clin Invest. 1993;92:638-643.
14. Staprans I, Pan X-M, Miller M, Rapp JH. Effect of dietary lipid peroxides on metabolism of serum chylomicrons in rats. Am J Physiol. 1993;264:G561-G568.
15. Staprans I, Rapp JH, Pan XM, Kim KY, Feingold KR. Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler Thromb. 1994;14:1900-1905.
16. Naruszewicz M, Wozny E, Mirkiewicz E, Nowicka G, Szostak WB. The effect of thermally oxidized soya bean oil on metabolism of chylomicrons: increased uptake and degradation of oxidized chylomicrons in cultured mouse macrophages. Atherosclerosis. 1987;66:45-53.
17. Frankel EN, Smith LM, Hamblin CL, Creveling RK, Clifford AJ. Occurrence of cyclic fatty acid monomers in frying oils used for fast foods. J Am Oil Chem Soc. 1984;61:87-90.
18. Alexander JC. Heated and oxidized fats. Prog Clin Biol Res. 1986;222:185-209.
19. Thompson JA, Paulose MM, Reddy BR, Krishnamurthy RG, Chang SS. A limited survey of fats and oils commercially used for deep fat frying. Food Technol. 1967;21:405-407.
20. Thompson LU, Aust R. Lipid changes in french fries and heated oils during commercial deep frying and their nutritional and toxicological implications. Can Inst Sci Technol J. 1983;16:246-253.
21. Yagi K, Kiuchi K, Saito Y, Miike A, Kayahara N, Tatano T, Ohishi N. Use of a new methylene blue derivative for determination of lipid peroxides in foods. Biochem Int. 1986;12:367-371.
22. Andrews JS, Griffith WH, Mead JF, Stein RA. Toxicity of airoxidized soybean oil. J Nutr. 1960;70:199-210.
23. Kubow S. Routes of formation and toxic consequences of lipid oxidation products in foods. Free Radic Biol Med. 1992;12:63-81.
24. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
25. Corongiu FP, Banni S, Dessi MA. Conjugated dienes detected in tissue lipid extracts by second derivative spectrophotometry. Free Radic Biol Med. 1989;7:183-186.
26. Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956;35:150-154.
27. Ohishi N, Ohkawa H, Miike A, Tatano T, Yagi K. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int. 1985;10:205-211.
28. Rapp JH, Connor WE, Lin DS, Inahara T, Porter JM. Lipids in human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res. 1983;24:1329-1335.
29. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.
30. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993;21:225-232.
31. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
32. Ha YL, Csallany SC. Separation of alpha-tocopherol and its oxidation products by high performance liquid chromatography. Lipids. 1988;23:359-361.
33. Neter J, Wasserman W, Kutner MH. In: Indicator variables. Applied Linear Statistical Models: Regression Analysis of Variance and Experimental Designs. Homewood, Ill: Richard D Irwin Inc; 1985:328-376.
34. Mahley RW. Alterations in plasma lipoproteins induced by cholesterol feeding in animals including man. In: Dietschy JM, Gotto AM, Ontko JA, eds. Disturbances in Lipid and Lipoprotein Metabolism. Bethesda, Md: American Physiological Society; 1978:181-197.
35. Slender S, Slender I, Nordestgaard B, Kjeldsen K. No effect of nifedipine on atherogenesis in cholesterol-fed rabbits. Arteriosclerosis. 1984;4:389-394.
36. Aw TY, Williams MW, Gray L. Absorption and lymphatic transport of peroxidized lipids by rat small intestine in vivo: role of mucosal GSH. Am J Physiol. 1992;262:G99-G106.
37. Mahley RW, Innerarity TL, Brown MS, Ho YK, Goldstein JL. Cholesteryl ester synlhesis in macrophages: slimulalion by β-very low density lipoproteins from choleslerol-fed animals of several species. J Lipid Res. 1980;21;970-980.
38. Van Lenten BJ, Fogelman AM, Hokom MM, Benson L, Haberland ME, Edwards PA. Regulalion of the uptake and degradation of β-very low density lipoprotein in human monocyte-macrophages. J Biol Chem. 1983;258:5151-5157.
39. St Clair RW, Randolph RK, Jokinen MP, Clarkson TB, Barakat HA. Relationship of plasma lipoproleins and the monocyte-macrophage system to atherosclerosis seventy in cholesterol-fed pigeons. Arteriosclerosis. 1986;6:614-626.
40. Sevanian A, McLeod LL. Cholesterol autoxidation in phospholipid membrane bilayers. Lipids. 1987;9:627-636.
41. Kaunitz H, Johnson RE, Pegus L. A long-term nutritional study with fresh and mildly oxidized vegetable and animal fats. J Am Oil Chem Soc. 1965;42:770-774.
42. Kritchevsky D, Tepper SA. Cholesterol vehicle in experimental atherosclerosis, part 9: comparison of heated corn oil and heated olive oil. J Atheroscler Res. 1967;7:647-651.
43. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of beta-very low density lipoprotein: potential role of monocyte recruitment and foam cell formation. Arteriosclerosis. 1989;9:398-404.
44. Haratz D, Stein O, Shwartz R, Berry EM, Stein Y. Preferential metabolism by macrophages of conditioned rabbit hypercholesterolemic remnant lipoproteins. Biochim Biophys Acta. 1988;959:127-133.
45. Davis JB, Bowyer DE. Macrophages modify β-VLDL by proteolysis and enhance subsequent lipid accumulation in arterial smooth muscle cells. Atherosclerosis. 1989;77:203-208.
46. Horrigan S, Campbell JH, Campbell GR. Oxidation of beta-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. Arterioscler Thromb. 1991;11:279-289.
47. Thomas CE, Jackson RL. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exp Ther. 1991;256:1182-1188.
48. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF, Morel DW, DiCorleto PE. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is a primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994;91:11452-11456.
49. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.